Bill Maughan's Stock Ratings

Canaccord Genuity Analyst

Bill Maughan is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/22/2025

Overall Average Return

-46.3%

Smart Score

19.1%

Overall Average Return Percentile

3rd

Number of Ratings

14
Buy NowGet Alert
08/13/2024YMABBuy Now
Y-mAbs Therapeutics
$4.75447.37%
Bill Maughan19%
$26 → $26MaintainsBuyGet Alert
05/10/2024NKTXBuy Now
Nkarta
$1.46927.4%
Bill Maughan19%
$16 → $15MaintainsBuyGet Alert
05/10/2024FATEBuy Now
Fate Therapeutics
$0.91889.01%
Bill Maughan19%
$11 → $9MaintainsBuyGet Alert
05/09/2024IMCRBuy Now
Immunocore Hldgs
$29.81124.76%
Bill Maughan19%
$63 → $67MaintainsHoldGet Alert
05/03/2024MRNABuy Now
Moderna
$32.73223.86%
Bill Maughan19%
$91 → $106MaintainsHoldGet Alert
03/26/2024NKTXBuy Now
Nkarta
$1.46995.89%
Bill Maughan19%
$15 → $16MaintainsBuyGet Alert
03/15/2024IPSCBuy Now
Century Therapeutics
$0.564185.71%
Bill Maughan19%
$22 → $24MaintainsBuyGet Alert
03/04/2024YMABBuy Now
Y-mAbs Therapeutics
$4.75447.37%
Bill Maughan19%
$22 → $26MaintainsBuyGet Alert
02/29/2024IMCRBuy Now
Immunocore Hldgs
$29.81111.34%
Bill Maughan19%
$60 → $63MaintainsHoldGet Alert
02/23/2024MRNABuy Now
Moderna
$32.73178.03%
Bill Maughan19%
$82 → $91MaintainsHoldGet Alert
02/21/2024BCYCBuy Now
Bicycle Therapeutics
$9.08560.79%
Bill Maughan19%
→ $60ReiteratesBuy → BuyGet Alert
11/29/2023MRNABuy Now
Moderna
$32.73150.53%
Bill Maughan19%
→ $82Initiates → HoldGet Alert
11/02/2023MRUSBuy Now
Merus
$47.24-4.74%
Bill Maughan19%
→ $45Initiates → BuyGet Alert
07/17/2023IMCRBuy Now
Immunocore Hldgs
$29.81124.76%
Bill Maughan19%
→ $67Initiates → HoldGet Alert